Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
  • Ipsos
  • Insights Hub
  • Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?

Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?

GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.

Healthcare Vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?With public understanding divided on the causes of obesity, this paper aims to transcend the debate between personal responsibility and disease status to offer a fresh perspective – that obesity is an evolutionary trap. Specifically, it examines:

  • Why human biology creates an inherent vulnerability to obesity
  • How amplifying our natural GLP-1 levels can address multiple different diseases
  • The current status of GLP-1 drug approvals by condition
  • The unprecedented questions we now face about equity, access & our collective future

Read our thought-provoking analysis today

Related news

  • NASPL Possible NW
    Consumer Behavior Event

    NASPL Possible NW

    Join Ipsos as we unveil how lotteries are using mystery shopping to unlock revenue hiding in plain sight, with high-performing retailers generating significantly more revenue per square foot through specific, measurable behaviours that any retailer can replicate.
  • [WEBINAR] 2025 KEYS: The Year in Review
    Consumers Events replay

    [WEBINAR] 2025 KEYS: The Year in Review

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Coffee Association of Canada Conference
    Consumers Event

    Coffee Association of Canada Conference

    We’re excited to announce that Ipsos will be speaking at the Coffee Association of Canada’s Annual Conference on November 5 at Angus Glen Golf Club!